Private Equity Portfolio News: Shoreline Biosciences Announces $140 million Financing to Advance Pipeline of Next Generation Cell Immunotherapies
Financing accelerates the growth of Shoreline’s pipeline of iPSC-based cell immunotherapies for the treatment of seriously ill patients and enables the buildout of smart manufacturing capabilities SAN DIEGO, Nov. 2, 2021 /PRNewswire/…